Recent News for OCX - OncoCyte Corporation

Date Title
Oct 9 What Kind Of Shareholders Own OncoCyte Corporation (NYSEMKT:OCX)?
Oct 1 OncoCyte Closes Initial Investment in Razor Genomics and Acquires Rights to Commercialize Razor Lung Cancer Treatment Stratification Test
Sep 25 PRO+ Small And Micro Newsletter: Boxlight, Mallinckrodt, The Habit
Sep 19 OncoCyte: Promising Future In The Field Of Liquid Biopsy Tests
Sep 12 Midday Gainers / Losers
Sep 12 Sintx Technologies leads healthcare gainers; Tocagen leads the losers
Sep 5 Oncocyte -15% with 12.4M shares on block
Sep 5 OncoCyte to acquire Razor Genomics
Aug 15 The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
Aug 15 Edited Transcript of OCX earnings conference call or presentation 14-Aug-19 8:30pm GMT
Aug 15 OncoCyte Corporation (OCX) CEO Ronald Andrews on Q2 2019 Results - Earnings Call Transcript
Aug 14 OncoCyte EPS misses by $0.01
Aug 14 OncoCyte Provides Corporate Update and Reports Second Quarter 2019 Financial Results
Aug 14 The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering
Aug 1 Genetic testers rally on insurance coverage for Myriad's GeneSight
Jul 31 OncoCyte to Report Second Quarter 2019 Financial Results on Wednesday, August 14, 2019
Jul 26 Lifshitz & Miller LLP Announces Investigation of Acer Therapeutics Inc., Aclaris Therapeutics, Inc., Ideanomics, Inc., L Brands, Inc., Marriott International, Inc., NRC Group Holdings Corp., Omnicell, Inc., and OncoCyte Corporation
Jul 24 OncoCyte Strengthens Board of Directors with Addition of Industry Veteran Melinda Griffith
Jul 11 Is OncoCyte Corporation (NYSEMKT:OCX) Trading At A 47% Discount?
Jul 9 HELE, WDFC and LEVI among after hour movers
Jul 7 Insiders Roundup: OncoCyte, BioSciences
Jul 2 BioTime sells partial stake in OncoCyte for $4.5M; shares up 8% after hours
Jul 2 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OncoCyte Corporation - OCX
Jul 2 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of OncoCyte Corporation (OCX)
Jul 2 Amarin and Celyad among healthcare gainers; CEL-SCI and Oramed Pharmaceuticals among losers
Back to the Main OCX Page...